Capital One Gains 2.25 as Analysts Boost Targets and Institutional Buyers Increase Holdings Trading at 165th Volume Rank

Generated by AI AgentAinvest Volume Radar
Thursday, Sep 4, 2025 8:48 pm ET1min read
COF--
Aime RobotAime Summary

- Capital One (COF) rose 2.25% to $226.00 on Sept 4, 2025, with Barclays and Citigroup raising price targets to $253 and $275 amid renewed analyst confidence.

- Institutional investors increased holdings (UBS, Bank of New York Mellon), while insiders sold shares (16.77%-12.83% ownership reductions) and Southpoint Capital cut its stake by 11.5%.

- Earnings beat $5.48 EPS with 31.4% revenue growth ($12.49B), but a 123%+ payout ratio and insider sales ($4.23M) raised valuation concerns despite a 1.1% yield.

- Analysts maintain "Moderate Buy" (avg $238.81 target), with 16 upgraded to "Strong Buy"/"Buy," as COF's 28.05% YTD return and $145.44B market cap highlight sector strength.

On September 4, 2025, Capital One FinancialCOF-- (COF) rose 2.25% to $226.00, with a trading volume of 0.59 billion shares, ranking 165th in market activity. Analysts at BarclaysBCS-- and CitigroupC-- raised price targets to $253 and $275, respectively, reflecting renewed confidence in the stock. Institutional investors, including Bank of New York MellonBK-- and UBSUBS--, increased holdings, while Southpoint Capital Advisors reduced its stake by 11.5% in Q1. The company’s quarterly dividend of $0.60, yielding 1.1%, was announced, though its payout ratio exceeds 123%. Insider sales, including 5,515 shares by Michael Zamsky and 10,114 shares by Robert M. Alexander, reduced ownership stakes by 16.77% and 12.83%, respectively. Earnings results showed a $5.48 EPS beat, driven by a 31.4% revenue increase to $12.49 billion.

The stock’s 52-week high of $232.45 and market cap of $145.44 billion highlight its strong position in the financial sector. Analysts maintain a “Moderate Buy” rating, with an average target of $238.81, though three analysts upgraded to “Strong Buy” and thirteen to “Buy” in recent reports. Institutional ownership now accounts for 89.84% of shares, with major investors including UBS and Bank of New York Mellon. Despite insider sales totaling $4.23 million over 90 days, the stock remains a key focus for institutional portfolios. The company’s elevated payout ratio and recent analyst upgrades suggest a balance between growth optimism and valuation concerns.

Backtesting results indicate the stock has outperformed benchmarks, with a 28.05% year-to-date return and a 59.34% gain over one year. Its beta of 1.17 and 116.63 P/E ratio reflect higher volatility and valuation compared to peers. Institutional buying and analyst upgrades could support further gains, but elevated payout ratios and insider sales may temper momentum. The stock’s performance aligns with broader financial sector trends, including post-merger adjustments and earnings-driven optimism.

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet